CLINICAL_TRIALS
trial_result
· 2019-05-20
Clinical Trial Update: ZS Ph2/3 Dose-response Study in Japan [Phase 2, Phase 3]
Summary
Clinical trial update for a dose-response study in Japan across Phase 2/3 for hyperkalemia; study completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Hyperkalemia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-05-20